American agribusiness giant Cargill has unveiled plans for a $500 million canola oil processing plant in East Rockingham, Western Australia. The state produces more than 2 million tonnes of canola ...

Boyd Group Services (NYSE:BGSI) announced it has received all necessary regulatory clearances to finalize its acquisition of Joe Hudson’s Collision Center (JHCC), with the transaction scheduled to ...

Memphasys (ASX:MEM) has secured CE Mark approval for its Felix automated sperm selection system under the EU Medical Device Regulation, clearing the way for immediate commercial sales across Europe ...

Australian energy major Woodside Energy (ASX:WDS) has signed a nine-year liquefied natural gas supply agreement with Turkey's state-owned gas importer BOTAŞ, marking the company's first long-term ...

FactSet (NYSE:FDS) reported solid first-quarter results for fiscal 2026, with GAAP revenues rising 6.9% year-over-year to $607.6 million, and organic revenues increasing 6% to $600 million. The ...

Simble Solutions (ASX:SIS) announced a strategic acquisition of Next Nano, granting the company exclusive rights to a patented nanomaterial-based sensor technology developed at Macquarie University.

Beacon Minerals (ASX:BCN) has announced that its wholly owned subsidiary, Beacon Mining, has entered into a binding agreement to sell its non-core Mt Dimer tenement package in Western Australia to ...

Riot Platforms has launched a new $500 million at-the-market stock offering as its Bitcoin production declined in November. The move comes as the miner continues to sell a large share of its monthly ...

Serve Robotics (NASDAQ:SERV) announced it has successfully deployed more than 2,000 autonomous delivery robots, making it the largest sidewalk delivery fleet in the U.S. The company revealed that its ...

Global analytical science and device company Trajan Group (ASX:TRJ) has provided an operational update, reaffirming its FY25 revenue guidance of $160 million to $165 million, despite an evolving ...

Dimerix (ASX:DXB), a biopharmaceutical company developing treatments for kidney disease, has received feedback from the US Food and Drug Administration on its ACTION3 Phase 3 trial of DMX-200 in ...

Radiopharm Theranostics (ASX:RAD), ein biopharmazeutisches Unternehmen in der klinischen Phase, das innovative Radiopharmazeutika für die Onkologie entwickelt, gab bekannt, dass die US-amerikanische ...